Author

Sabina E W Leonard

Vanderbilt University Medical CenterORCID 0009-0007-7756-2756Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Approach:statistical model· 2

Frequent Co-Authors

Ivelin S. GeorgieviD· 3 shared James E. CroweiD· 2 shared Lindsay E BassiD· 2 shared Perry T. WasdiniD· 2 shared Rachel H. BonamiiD· 2 shared Ahmed Magdy KhaliliD· 1 shared Alaina M Skellett· 1 shared Alexandra A. Abu-ShmaisiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Ivelin S. GeorgievORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 22, 2026

Insulin-binding B cells can arise in early-stage type 1 diabetes individuals in the absence of somatic hypermutation or insulin autoantibody seropositivity

Lindsay E Bass, Tommi C Taylor, Mason V Forchetti…·Rachel H. Bonami

The paper identifies anti-insulin B cells in early-stage T1D patients without autoantibodies or somatic hypermutation, showing their role in autoimmunity.

DOI 10.64898/2026.10.20.760517

humanCITE-seq

𝕏 PostBluesky

ImmunologyCell Reports MethodsPeer-reviewedSep 1, 2026

Development and application of nbLIBRA-seq for high-throughput discovery of antigen-specific nanobodies

Sabina E W Leonard, Perry T. Wasdin, Katherine Webb…·Kelsey Voss

This paper develops and validates nbLIBRA-seq, a method for high-throughput antigen-specific nanobody discovery in immunized alpacas, demonstrating its effectiveness in identifying nanobodies against CD71 and viral antigens.

DOI 10.1016/j.crmeth.2026.101605

humanmouse

𝕏 PostBluesky

ImmunologyCell Reports MedicinePeer-reviewedJan 16, 2026

A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein

Alexandra A. Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil…·Ivelin S. Georgiev

The paper identifies a human antibody that neutralizes RSV and hMPV by targeting a novel epitope spanning multiple antigenic sites, showing cross-protection in a mouse model.

7 citationstop 1%

humanmouse

𝕏 PostBluesky